Nuclear DNA guanine N7 position (N7-G)

The N7 position of guanine in nuclear DNA is a critical nucleophilic site located within the major groove of the DNA double helix, making it highly susceptible to electrophilic attack by various therapeutic agents (PubMed: 15130167). It serves as the primary target for several major classes of anticancer drugs, including platinum-based compounds and alkylating agents (StatPearls: Cisplatin, 2023). When these drugs bind to the N7 nitrogen, they form stable covalent adducts that can result in DNA cross-links, which physically block the progression of DNA polymerase and RNA polymerase. This interference disrupts vital cellular functions such as DNA replication and gene expression, particularly in rapidly proliferating cancer cells. If the resulting DNA damage exceeds the cell's repair capacity, it activates the apoptotic pathway, leading to programmed cell death. However, because this target is universal to all genomic DNA, these treatments often exhibit significant toxicity toward healthy tissues and carry a risk of inducing secondary leukemias or other cancers (PubMed: 24511374).

Other names

N7-guanineGuanine N7DNA guanine N7N7-deoxyguanosineN7 position of guanine

Therapeutic agents target the nucleophilic N7 position of guanine to form covalent adducts, leading to DNA cross-linking (intrastrand and interstrand) and DNA strand breaks, which inhibit DNA replication and transcription, ultimately inducing apoptosis (StatPearls: Alkylating Agents, 2023; PubMed: 11473355).